D55.2 Anemia due to disorders of glycolytic enzymes

Name of the Condition

• Anemia due to disorders of glycolytic enzymes

Summary

Anemia due to disorders of glycolytic enzymes is a hemolytic anemia caused by deficiencies in enzymes involved in the glycolytic pathway, which is critical for red blood cell energy production. These deficiencies impair the cell's ability to maintain structural integrity and function, leading to premature destruction of red blood cells. This results in reduced oxygen-carrying capacity and symptoms of anemia.

Causes

The condition arises from genetic mutations that reduce or eliminate the activity of specific glycolytic enzymes, such as pyruvate kinase or phosphofructokinase. These enzymes are essential for red blood cell metabolism and survival. The mutations are typically inherited and may be exacerbated by environmental triggers that increase metabolic stress.

Risk Factors

• Genetic predisposition (inherited glycolytic enzyme deficiencies)
• Exposure to oxidative stressors (e.g., certain medications, infections, or chemicals)
• Family history of hemolytic anemia
• Underlying metabolic disorders affecting glycolytic pathways

Symptoms

• Fatigue and weakness
• Pale skin or jaundice
• Shortness of breath
• Dark urine (in acute hemolysis)
• Rapid heart rate
• Enlarged spleen (splenomegaly)

Diagnosis

Diagnosis involves blood tests to assess red blood cell count, hemoglobin levels, and reticulocyte count, along with specific enzyme activity assays (e.g., pyruvate kinase or phosphofructokinase levels). Additional tests may include hemoglobin electrophoresis or genetic testing to confirm the underlying enzymatic defect.

Treatment Options

Treatment focuses on managing hemolysis and addressing symptoms. This may include blood transfusions for severe anemia, avoiding known triggers (e.g., certain medications), and supportive care. In some cases, splenectomy may be considered to reduce red blood cell destruction. Genetic counseling is recommended for affected individuals and their families.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the enzymatic deficiency and the presence of triggers. With appropriate management, many individuals can lead relatively normal lives. Regular follow-up with a hematologist is important to monitor hemoglobin levels, manage complications, and adjust treatment as needed.

Complications

• Severe anemia requiring transfusions
• Increased risk of infections
• Gallstones (due to chronic hemolysis)
• Splenomegaly or splenic rupture
• Developmental delays in severe cases (rare)

Lifestyle & Prevention

• Avoid known triggers (e.g., certain medications, infections, or chemicals)
• Maintain a balanced diet to support overall health
• Stay hydrated to support red blood cell function
• Follow up regularly with a healthcare provider for monitoring

When to Seek Professional Help

Seek medical attention if you experience symptoms of anemia, such as severe fatigue, shortness of breath, or jaundice, especially if you have a known family history of hemolytic anemia. Prompt evaluation is important to prevent complications and initiate appropriate treatment.

Tips for Medical Coders

When coding for anemia due to disorders of glycolytic enzymes (D55.2), ensure documentation supports the specific enzymatic deficiency (e.g., pyruvate kinase deficiency) and any associated triggers or complications. Verify that the diagnosis aligns with clinical findings and laboratory results to support accurate code assignment.